Rare Disease Registries Market Report 2026

Rare Disease Registries Market Overview

• Rare Disease Registries market size has reached to $1.62 billion in 2025 • Expected to grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.9% • Growth Driver: Surge In Government Initiatives And Funding Support Fueling The Growth Of The Market Due To Enhanced Policy Decisions, Targeted Resource Allocation, And Strengthened Healthcare Programs • Market Trend: NORD Launches First Canadian Rare Disease Registries with AI-Enabled Capabilities • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rare Disease Registries Market?

Rare disease registries are organized databases that systematically collect and store information on patients affected by rare medical conditions. They enable longitudinal tracking of disease progression, treatment outcomes, and epidemiological patterns. These registries support research, clinical decision-making, and the development of new therapies by providing reliable and structured patient data. The main types of rare disease registries include product registries, health services registries, and disease registries. Product registries refer to organized databases that track patient outcomes and safety information for specific therapies or interventions. The database types include population-based and hospital-based with software types including standalone and integrated solutions. The various functions involved are data collection, data analysis, patient recruitment, and others, and they are used by several end users such as pharmaceutical companies, research organizations, hospitals, government agencies, and other end users.

What Is The Rare Disease Registries Market Growth Forecast?

The rare disease registries market size is expected to see rapid growth in the next few years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to adoption of ai-driven registry solutions, integration with genomic and omics data, expansion of personalized medicine initiatives, investment in cloud-based interoperable platforms, enhanced patient engagement and data sharing. Major trends in the forecast period include real-time patient data collection, integration with electronic health records (ehr), advanced data analytics for rare diseases, patient recruitment and retention optimization, interoperable registry platforms.

Global Rare Disease Registries Market Segmentation

1) By Type: Product Registries, Health Services Registries, Disease Registries 2) By Database Type: Population-based, Hospital-based 3) By Software: Standalone, Integrated 4) By Function: Data Collection, Data Analysis, Patient Recruitment, Other Functions 5) By End-User: Pharmaceutical Companies, Research Organizations, Hospitals, Government Agencies, Other End-Users Subsegments: 1) By Product Registries: Drug Product Registries, Biologic Product Registries, Medical Device Registries, Gene Therapy Product Registries 2) By Health Services Registries: Hospital Based Registries, Clinic Based Registries, National Health Program Registries, Insurance Claims Registries 3) By Disease Registries: Genetic Disorder Registries, Metabolic Disorder Registries, Neurological Disorder Registries, Oncology Rare Disease Registries

What Is The Driver Of The Rare Disease Registries Market?

The growing government initiatives and funding support are expected to drive the expansion of the rare disease registries market over the forecast period. Government initiatives and funding support encompass public-sector programs and financial investments aimed at strengthening healthcare infrastructure, promoting innovation, and improving service delivery. The increasing public funding reflects efforts to enhance data-driven policymaking, optimize resource allocation, and improve outcomes for underserved patient populations, including individuals with rare diseases. Rare disease registries play a critical role in supporting these objectives by aggregating comprehensive patient data that inform policy decisions, facilitate targeted funding allocation, and enable the design and evaluation of effective healthcare and research programs. For instance, in February 2025, the UK government’s central executive authority committed approximately £26 billion ($35 billion) over two years to support the health and care system, reinforcing investment in data infrastructure and population health initiatives. Therefore, the growing government initiatives and funding support is driving the growth of the rare disease registries industry.

Key Players In The Global Rare Disease Registries Market

Major companies operating in the rare disease registries market are disease registries market are Deloitte Touche Tohmatsu Limited, International Business Machines Corporation, Oracle Corporation, BC Platforms Ltd., IQVIA Holdings Inc., ICON plc, Veeva Systems Inc., Alira Health Inc., Phastar Ltd., HealthVerity Inc., OM1 Inc., Synapse Laboratory, Castor EDC, RedCap Cloud, Within3 Inc., Sage Bionetworks, National Organization for Rare Disorders Inc., RTI Health Solutions, ArborMetrix Inc., Evado Clinical Systems Ltd., ClinCapture LLC, Global Vision Technologies Inc., Genetic Alliance UK, Pulse Infoframe.

Global Rare Disease Registries Market Trends and Insights

Major companies operating in the rare disease registries market are focusing on developing advanced products such as, an AI-enabled patient registry infrastructure to enhance real-time data capture, patient monitoring, and research insights across rare diseases. AI-enabled patient registry infrastructure refers to registry systems that leverage artificial intelligence to process, analyze, and interpret large-scale patient and clinical data efficiently, enabling predictive analytics, natural history modeling, and real-world evidence generation. For instance, in May 2024, National Organization for Rare Disorders (NORD), US-based non-profit advocacy organization dedicated to individuals with rare diseases and the organizations that serve them, launched the first Canadian rare disease patient registries on its IAMRARE platform for phenylketonuria (PKU) and mucopolysaccharidoses (MPS), allowing real-time cooperative data collection, supporting multiple languages and regional consent requirements, and providing valuable insights for clinical trial eligibility, disease progression tracking, and treatment evaluation.

What Are Latest Mergers And Acquisitions In The Rare Disease Registries Market?

In October 2023, IQVIA Holdings Inc., a US-based healthcare data, analytics, and technology solutions provider, acquired Open Applications Consulting Limited (OpenApp) for an undisclosed amount. With this acquisition, IQVIA expanded its capabilities in patient registry software and real-world evidence solutions, enhancing its ability to build, deploy, and scale disease-specific registries by integrating OpenApp’s customizable registry platforms to support longitudinal data capture, research insights, and clinical program requirements across rare and chronic conditions. Open Applications Consulting Limited (OpenApp) is an Ireland-based health technology company that develops patient registry and health intelligence software used to collect and manage disease-specific clinical and real-world data, including platforms supporting rare disease and low-prevalence condition registries.

Regional Insights

North America was the largest region in the rare disease registries market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rare Disease Registries Market?

The rare disease registries market includes revenues earned by entities through epidemiological tracking, outcomes monitoring, and data quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Rare Disease Registries Market Report 2026?

The rare disease registries market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease registries industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.